Altimmune, Inc. - ALT
Insiders (Form 4) · last 180 days · showing up to 200 transactions
· Form 144 is shown in the SEC filings tab
· Updating…
Visible: 0
Transaction codes:
P = Open-market purchase ·
S = Open-market sale ·
A = Grant/award ·
M = Exercise/conversion of derivative ·
G = Gift ·
F = Tax withholding ·
J = Other ·
A/D:
A = Acquired (buy/receive) ·
D = Disposed (sell/give)
| Filed | Owner | Title | Code | A/D | Shares | Price | Value | Shares after | SEC |
|---|---|---|---|---|---|---|---|---|---|
| May 01, 2026 | — | A | A | 48,800.0 | 0.0 | 0.0 | 48,800.0 | View | |
| May 01, 2026 | — | A | A | 48,800.0 | 0.0 | 0.0 | 48,800.0 | View | |
| May 01, 2026 | — | A | A | 48,800.0 | 0.0 | 0.0 | 48,800.0 | View | |
| May 01, 2026 | — | A | A | 48,800.0 | 0.0 | 0.0 | 48,800.0 | View | |
| May 01, 2026 | — | A | A | 48,800.0 | 0.0 | 0.0 | 48,800.0 | View | |
| May 01, 2026 | — | A | A | 48,800.0 | 0.0 | 0.0 | 48,800.0 | View | |
| May 01, 2026 | — | A | A | 48,800.0 | 0.0 | 0.0 | 48,800.0 | View | |
| May 01, 2026 | — | A | A | 48,800.0 | 0.0 | 0.0 | 48,800.0 | View | |
| Apr 06, 2026 | — | P | A | 9,200.0 | 3.4076 | 31,349.92 | 21,700.0 | View | |
| Apr 01, 2026 | President and CEO | P | A | 15,000.0 | 3.14 | 47,100.0 | 47,500.0 | View | |
| Apr 01, 2026 | Chief Financial Officer | P | A | 10,000.0 | 3.1499 | 31,499.0 | 38,078.0 | View | |
| Mar 09, 2026 | President and CEO | P | A | 20,000.0 | 3.5395 | 70,790.0 | 32,500.0 | View | |
| Mar 09, 2026 | Chief Financial Officer | P | A | 5,000.0 | 3.54 | 17,700.0 | 28,078.0 | View | |
| Feb 27, 2026 | Chief Scientific Officer | A | A | 95,430.0 | 0.0 | 0.0 | 95,430.0 | View | |
| Feb 27, 2026 | Chief Scientific Officer | A | A | 222,670.0 | 0.0 | 0.0 | 222,670.0 | View | |
| Feb 27, 2026 | Chief Financial Officer | A | A | 111,000.0 | 0.0 | 0.0 | 111,000.0 | View | |
| Feb 27, 2026 | Chief Financial Officer | A | A | 259,000.0 | 0.0 | 0.0 | 259,000.0 | View | |
| Feb 03, 2026 | Chief Scientific Officer | M | D | 7,775.0 | 0.0 | 0.0 | 0.0 | View | |
| Feb 03, 2026 | Chief Scientific Officer | M | D | 9,275.0 | 0.0 | 0.0 | 9,275.0 | View | |
| Feb 03, 2026 | Chief Scientific Officer | F | D | 2,329.0 | 5.55 | 12,925.95 | 112,824.0 | View | |
| Feb 03, 2026 | Chief Scientific Officer | M | A | 7,775.0 | 0.0 | 0.0 | 115,153.0 | View | |
| Feb 03, 2026 | Chief Scientific Officer | A | A | 5,567.0 | 3.07 | 17,090.69 | 107,378.0 | View | |
| Feb 03, 2026 | Chief Scientific Officer | F | D | 2,859.0 | 5.6 | 16,010.4 | 101,811.0 | View | |
| Feb 03, 2026 | Chief Scientific Officer | M | A | 9,275.0 | 0.0 | 0.0 | 104,670.0 | View | |
| Feb 02, 2026 | — | M | D | 26,775.0 | 0.0 | 0.0 | 26,775.0 | View | |
| Feb 02, 2026 | — | A | A | 6,926.0 | 3.07 | 21,262.82 | 424,519.0 | View | |
| Feb 02, 2026 | — | F | D | 11,632.0 | 5.6 | 65,139.2 | 417,593.0 | View | |
| Feb 02, 2026 | — | M | A | 26,775.0 | 0.0 | 0.0 | 429,225.0 | View | |
| Feb 02, 2026 | Chief Business Officer | A | A | 4,571.0 | 3.07 | 14,032.97 | 70,107.0 | View |